An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation

Journal of Experimental Medicine

Volumn 190, Issue 7, 1999, Pages 995-1003

  Asseman, Chrystelle ^a   Mauze, Smita ^b   Leach, Michael W ^b   Coffman, Robert L ^b   Powrie, Fiona ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

CD4+ T lymphocyte; Inflammatory bowel disease; Interleukin 10; Regulatory T lymphocyte

Indexed keywords

CD45 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; ISOPROTEIN; RECEPTOR ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COLITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE SUBPOPULATION;

EID: 0033523607     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.190.7.995     Document Type: Article

References (33)

1. Elson, C.O., R.B. Sartor, G.S. Tennyson, and R.H. Riddell. 1995. Experimental models of inflammatory bowel disease. Gastroenterology. 109:1344-1367.
2. Powrie, F., and M.W. Leach. 1995. Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation. Ther. Immunol 2:115-123.
3. + T cells. J. Exp. Med. 178:237-244.
4. + T cells induce or protect from chronic intestinal inflammation in C.B-17 scid mice. Int. Immunol. 5:1461-1471.
5. + T cells. Immunity. 1:553-562.
6. Simpson, S.J., S. Shah, M. Comiskey, Y.P. de Jong, B. Wang, E. Mizoguchi, A.K. Bhan, and C. Terhorst. 1998. T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon γ expression by T cells. J. Exp. Med. 187:1225-1234.
7. + T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB phenotype. J. Immunol. 162:3702-3710.
8. + T cells. J. Exp. Med. 183:2669-2674.
9. Kühn, R., J. Löhler, D. Rennick, K. Rajewsky, and W. Müller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell. 75:263-274.
10. + TH1-like responses. J. Clin. Invest. 98: 1010-1020.
11. Hagenbaugh, A., S. Sharma, S.M. Dubinett, S.H. Wei, R. Aranda, H. Cheroutre, D.J. Fowell, S. Binder, B. Tsao, R.M. Locksley, et al. 1997. Altered immune response in interleukin 10 transgenic mice. J. Exp. Med. 185:2101-2110.
12. Coffman, R.L. 1982. Surface antigen expression and immunoglobulin gene rearrangement during mouse pre-B cell development. Immunol. Rev. 69:5-23.
13. O'Farrel, A.-M., Y. Liu, K.W. Moore, and A.L.-F. Mui. 1998. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: evidence for Stat3-dependent and -independent pathways. EMBO (Eur. Mol. Biol. Organ.) J. 17:1006-1018.
14. Abrams, J.S., M.G. Roncarolo, H. Yssel, U. Andersson, G.J. Gleich, and J.E. Silver. 1992. Strategies of anti-cytokine monoclonal antibody development: immunoassay of IL-10 and IL-5 in clinical samples. Immunol. Rev. 127:5-24.
15. Openshaw, P., E.E. Murphy, N.A. Hosken, V. Maino, K. Davis, K. Murphy, and A. O'Garra. 1995. Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations. J. Exp. Med. 182:1357-1367.
16. Gershon, R.K., and K. Kondo. 1971. Infectious immunological tolerance. Immunology. 21:903-914.
17. Qin, S., S.P. Cobbold, H. Pope, J. Elliott, D. Kioussis, J. Davies, and H. Waldmann. 1993. "Infectious" transplantation tolerance. Science. 259:974-977.
18. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis, Nature. 389:737-742.
19. Davidson, N.J., S.A. Hudak, R.E. Lesley, S. Menon, M.W. Leach, and D.M. Rennick. 1998. IL-12, but not IFN-γ, plays a major role in sustaining the chronic phase of colitis in IL-10-deficient mice. J. Exp. Med. 161:3143-3149.
20. high T cells to SCID recipients. J. Immunol. 158:3464-3473.
21. Kullberg, M.C., J.M. Ward, P.L. Gorelick, P. Caspar, S. Hieny, A. Cheever, D. Jankovic, and A. Sher. 1998. Helicobacter hepaticus triggers colitis in specific-pathogen-free interleukin-10 (IL-10)-deficient mice through an IL-12- and gamma interferon-dependent mechanism. Infect. Immun. 66: 5157-5166.
22. + T cell down-regulation in human intestinal mucosa: evidence for intestinal tolerance to luminal bacterial antigens. J. Immunol. 158:3626-3634.
23. Moore, K.W., A. O'Garra, R. de Waal Malefyt, P. Vieira, and T.R. Mosmann. 1993. Interleukin-10. Annu. Rev. Immunol. 11:165-190.
24. Takeda, K., B.E. Clausen, T. Kaisho, T. Tsujimura, N. Terada, I. Förster, and S. Akira. 1999. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils. Immunity. 10:39-49.
25. + T cells: a population of T cells with immune regulatory activities in vitro. Eur. J. Immunol. 28:3435-3447.
26. Shull, M.M., I. Ormsby, A.B. Kier, S. Pawlowski, R.J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammation. Nature. 359:693-699.
27. Maeda, H., H. Kuwahara, Y. Ichimura, M. Ohtsuki, S. Kurakata, and A. Shiraishi. 1995. TGF-β enhances macrophage ability to produce IL-10 in normal and tumor-bearing mice. J. Immunol. 155:4926-4932.
28. Chen, Y., V.K. Kuchroo, J.-I. Inobe, D.A. Hafler, and H.L. Weiner. 1994. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science: 265:1237-1240.
29. Neurath, M.F., I. Fuss, B.L. Kelsall, D.H. Presky, W. Waegell, and W. Strober. 1996. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β-mediated oral tolerance. J. Exp. Med. 183:2605-2616.
30. Mason, D., and F. Powrie. 1998. Control of immune pathology by regulatory T cells, Curr. Opin. Immunol. 10:649-655.
31. + T cell lines. J. Exp. Med. 185:1769-1775.
32. - thymocytes. J. Exp. Med. 189:279-288.
33. - (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10. J. Exp. Med. 187:1047-1056.